Respiratory Syncytial Virus Vaccines Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Palivizumab
1.2.3 RSVpreF PF06928316
1.2.4 RSVPreF3 OA (GSK3844766A)
1.2.5 mRNA-1345
1.2.6 Janssen RSV Vaccine
1.2.7 ResVax
1.2.8 Nirsevimab (MEDI8897)
1.2.9 MVA-BN RSV
1.3 Market by Application
1.3.1 Global Respiratory Syncytial Virus Vaccines Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Vaccines Market Perspective (2017-2028)
2.2 Respiratory Syncytial Virus Vaccines Growth Trends by Region
2.2.1 Respiratory Syncytial Virus Vaccines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Respiratory Syncytial Virus Vaccines Historic Market Size by Region (2017-2022)
2.2.3 Respiratory Syncytial Virus Vaccines Forecasted Market Size by Region (2023-2028)
2.3 Respiratory Syncytial Virus Vaccines Market Dynamics
2.3.1 Respiratory Syncytial Virus Vaccines Industry Trends
2.3.2 Respiratory Syncytial Virus Vaccines Market Drivers
2.3.3 Respiratory Syncytial Virus Vaccines Market Challenges
2.3.4 Respiratory Syncytial Virus Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Vaccines Players by Revenue
3.1.1 Global Top Respiratory Syncytial Virus Vaccines Players by Revenue (2017-2022)
3.1.2 Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Players (2017-2022)
3.2 Global Respiratory Syncytial Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Syncytial Virus Vaccines Revenue
3.4 Global Respiratory Syncytial Virus Vaccines Market Concentration Ratio
3.4.1 Global Respiratory Syncytial Virus Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Vaccines Revenue in 2021
3.5 Respiratory Syncytial Virus Vaccines Key Players Head office and Area Served
3.6 Key Players Respiratory Syncytial Virus Vaccines Product Solution and Service
3.7 Date of Enter into Respiratory Syncytial Virus Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Syncytial Virus Vaccines Breakdown Data by Type
4.1 Global Respiratory Syncytial Virus Vaccines Historic Market Size by Type (2017-2022)
4.2 Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Type (2023-2028)
5 Respiratory Syncytial Virus Vaccines Breakdown Data by Application
5.1 Global Respiratory Syncytial Virus Vaccines Historic Market Size by Application (2017-2022)
5.2 Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
6.2 North America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
6.3 North America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
7.2 Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
7.3 Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
8.2 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
8.3 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
9.2 Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
9.3 Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
10.2 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
10.3 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer Inc.Pfizer Inc.
11.1.1 Pfizer Inc.Pfizer Inc. Company Detail
11.1.2 Pfizer Inc.Pfizer Inc. Business Overview
11.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Introduction
11.1.4 Pfizer Inc.Pfizer Inc. Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.1.5 Pfizer Inc.Pfizer Inc. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Respiratory Syncytial Virus Vaccines Introduction
11.2.4 Sanofi Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.2.5 Sanofi Recent Development
11.3 Merck Sharp & Dohme
11.3.1 Merck Sharp & Dohme Company Detail
11.3.2 Merck Sharp & Dohme Business Overview
11.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Introduction
11.3.4 Merck Sharp & Dohme Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.3.5 Merck Sharp & Dohme Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Introduction
11.4.4 GlaxoSmithKline Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Development
11.5 SOBI
11.5.1 SOBI Company Detail
11.5.2 SOBI Business Overview
11.5.3 SOBI Respiratory Syncytial Virus Vaccines Introduction
11.5.4 SOBI Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.5.5 SOBI Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Introduction
11.6.4 Johnson & Johnson Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.6.5 Johnson & Johnson Recent Development
11.7 Bavarian Nordic
11.7.1 Bavarian Nordic Company Detail
11.7.2 Bavarian Nordic Business Overview
11.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Introduction
11.7.4 Bavarian Nordic Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.7.5 Bavarian Nordic Recent Development
11.8 Novavax
11.8.1 Novavax Company Detail
11.8.2 Novavax Business Overview
11.8.3 Novavax Respiratory Syncytial Virus Vaccines Introduction
11.8.4 Novavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.8.5 Novavax Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Introduction
11.9.4 AstraZeneca Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.9.5 AstraZeneca Recent Development
11.10 Moderna
11.10.1 Moderna Company Detail
11.10.2 Moderna Business Overview
11.10.3 Moderna Respiratory Syncytial Virus Vaccines Introduction
11.10.4 Moderna Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.10.5 Moderna Recent Development
11.11 Codagenix
11.11.1 Codagenix Company Detail
11.11.2 Codagenix Business Overview
11.11.3 Codagenix Respiratory Syncytial Virus Vaccines Introduction
11.11.4 Codagenix Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.11.5 Codagenix Recent Development
11.12 Intravacc
11.12.1 Intravacc Company Detail
11.12.2 Intravacc Business Overview
11.12.3 Intravacc Respiratory Syncytial Virus Vaccines Introduction
11.12.4 Intravacc Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.12.5 Intravacc Recent Development
11.13 Alphavax
11.13.1 Alphavax Company Detail
11.13.2 Alphavax Business Overview
11.13.3 Alphavax Respiratory Syncytial Virus Vaccines Introduction
11.13.4 Alphavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.13.5 Alphavax Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Palivizumab
Table 3. Key Players of RSVpreF PF06928316
Table 4. Key Players of RSVPreF3 OA (GSK3844766A)
Table 5. Key Players of mRNA-1345
Table 6. Key Players of Janssen RSV Vaccine
Table 7. Key Players of ResVax
Table 8. Key Players of Nirsevimab (MEDI8897)
Table 9. Key Players of MVA-BN RSV
Table 10. Global Respiratory Syncytial Virus Vaccines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Respiratory Syncytial Virus Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Respiratory Syncytial Virus Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global Respiratory Syncytial Virus Vaccines Market Share by Region (2017-2022)
Table 14. Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global Respiratory Syncytial Virus Vaccines Market Share by Region (2023-2028)
Table 16. Respiratory Syncytial Virus Vaccines Market Trends
Table 17. Respiratory Syncytial Virus Vaccines Market Drivers
Table 18. Respiratory Syncytial Virus Vaccines Market Challenges
Table 19. Respiratory Syncytial Virus Vaccines Market Restraints
Table 20. Global Respiratory Syncytial Virus Vaccines Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global Respiratory Syncytial Virus Vaccines Market Share by Players (2017-2022)
Table 22. Global Top Respiratory Syncytial Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Vaccines as of 2021)
Table 23. Ranking of Global Top Respiratory Syncytial Virus Vaccines Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by Respiratory Syncytial Virus Vaccines Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Respiratory Syncytial Virus Vaccines Product Solution and Service
Table 27. Date of Enter into Respiratory Syncytial Virus Vaccines Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Type (2017-2022)
Table 31. Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Type (2023-2028)
Table 33. Global Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Application (2017-2022)
Table 35. Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Application (2023-2028)
Table 37. North America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 40. Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 41. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 42. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Region (2023-2028) & (US$ Million)
Table 43. Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 44. Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
Table 46. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
Table 47. Pfizer Inc.Pfizer Inc. Company Detail
Table 48. Pfizer Inc.Pfizer Inc. Business Overview
Table 49. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product
Table 50. Pfizer Inc.Pfizer Inc. Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 51. Pfizer Inc.Pfizer Inc. Recent Development
Table 52. Sanofi Company Detail
Table 53. Sanofi Business Overview
Table 54. Sanofi Respiratory Syncytial Virus Vaccines Product
Table 55. Sanofi Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Merck Sharp & Dohme Company Detail
Table 58. Merck Sharp & Dohme Business Overview
Table 59. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product
Table 60. Merck Sharp & Dohme Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 61. Merck Sharp & Dohme Recent Development
Table 62. GlaxoSmithKline Company Detail
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product
Table 65. GlaxoSmithKline Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. SOBI Company Detail
Table 68. SOBI Business Overview
Table 69. SOBI Respiratory Syncytial Virus Vaccines Product
Table 70. SOBI Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 71. SOBI Recent Development
Table 72. Johnson & Johnson Company Detail
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Respiratory Syncytial Virus Vaccines Product
Table 75. Johnson & Johnson Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Bavarian Nordic Company Detail
Table 78. Bavarian Nordic Business Overview
Table 79. Bavarian Nordic Respiratory Syncytial Virus Vaccines Product
Table 80. Bavarian Nordic Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 81. Bavarian Nordic Recent Development
Table 82. Novavax Company Detail
Table 83. Novavax Business Overview
Table 84. Novavax Respiratory Syncytial Virus Vaccines Product
Table 85. Novavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 86. Novavax Recent Development
Table 87. AstraZeneca Company Detail
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Respiratory Syncytial Virus Vaccines Product
Table 90. AstraZeneca Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Moderna Company Detail
Table 93. Moderna Business Overview
Table 94. Moderna Respiratory Syncytial Virus Vaccines Product
Table 95. Moderna Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 96. Moderna Recent Development
Table 97. Codagenix Company Detail
Table 98. Codagenix Business Overview
Table 99. Codagenix Respiratory Syncytial Virus VaccinesProduct
Table 100. Codagenix Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 101. Codagenix Recent Development
Table 102. Intravacc Company Detail
Table 103. Intravacc Business Overview
Table 104. Intravacc Respiratory Syncytial Virus VaccinesProduct
Table 105. Intravacc Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 106. Intravacc Recent Development
Table 107. Alphavax Company Detail
Table 108. Alphavax Business Overview
Table 109. Alphavax Respiratory Syncytial Virus VaccinesProduct
Table 110. Alphavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million)
Table 111. Alphavax Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Syncytial Virus Vaccines Market Share by Type: 2021 VS 2028
Figure 2. Palivizumab Features
Figure 3. RSVpreF PF06928316 Features
Figure 4. RSVPreF3 OA (GSK3844766A) Features
Figure 5. mRNA-1345 Features
Figure 6. Janssen RSV Vaccine Features
Figure 7. ResVax Features
Figure 8. Nirsevimab (MEDI8897) Features
Figure 9. MVA-BN RSV Features
Figure 10. Global Respiratory Syncytial Virus Vaccines Market Share by Application in 2021 & 2028
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Research Institute Case Studies
Figure 14. Respiratory Syncytial Virus Vaccines Report Years Considered
Figure 15. Global Respiratory Syncytial Virus Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Respiratory Syncytial Virus Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Respiratory Syncytial Virus Vaccines Market Share by Region: 2021 VS 2028
Figure 18. Global Respiratory Syncytial Virus Vaccines Market Share by Players in 2021
Figure 19. Global Top Respiratory Syncytial Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Vaccines as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus Vaccines Revenue in 2021
Figure 21. North America Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. North America Respiratory Syncytial Virus Vaccines Market Share by Country (2017-2028)
Figure 23. United States Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Respiratory Syncytial Virus Vaccines Market Share by Country (2017-2028)
Figure 27. Germany Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Respiratory Syncytial Virus Vaccines Market Share by Region (2017-2028)
Figure 35. China Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Respiratory Syncytial Virus Vaccines Market Share by Country (2017-2028)
Figure 43. Mexico Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Brazil Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Share by Country (2017-2028)
Figure 47. Turkey Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Saudi Arabia Respiratory Syncytial Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Pfizer Inc.Pfizer Inc. Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 50. Sanofi Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 51. Merck Sharp & Dohme Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 53. SOBI Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 54. Johnson & Johnson Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 55. Bavarian Nordic Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 56. Novavax Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 57. AstraZeneca Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 58. Moderna Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 59. Codagenix Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 60. Intravacc Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 61. Alphavax Revenue Growth Rate in Respiratory Syncytial Virus Vaccines Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
